Jpmorgan Chase & Co »

Actinium Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Actinium Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Actinium Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actinium Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $94k 19k 5.08
2023-09-30 $107k 18k 5.92
2023-06-30 $150k 20k 7.42